Kingswood Wealth Advisors’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,500
Closed -$116K 789
2025
Q1
$116K Buy
33,500
+2,400
+8% +$11.6K 0.01% 702
2024
Q4
$320K Buy
31,100
+10,200
+49% +$127K 0.02% 585
2024
Q3
$283K Buy
20,900
+2,000
+11% +$24.8K 0.02% 586
2024
Q2
$246K Buy
+18,900
New +$234K 0.02% 580

Other funds holding THRD

Kingswood Wealth Advisors's THRD Position: Q2 2025 in Review

Kingswood Wealth Advisors sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 33,500 shares — an estimated $116K sold.

Kingswood Wealth Advisors first reported a position in THRD in Q2 2024 and held it in 4 quarters. The position peaked at $320K in Q4 2024. 106 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Kingswood Wealth Advisors reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Kingswood Wealth Advisors sold 33,500 Third Harmonic Bio shares in Q2 2025, an estimated $116K.
  • Kingswood Wealth Advisors first reported a position in Third Harmonic Bio in Q2 2024 and held it in 4 quarters.
  • Kingswood Wealth Advisors's Third Harmonic Bio position peaked at $320K in Q4 2024.
  • 106 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.